The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...

AstraZeneca Pharma India Ltd. has received approval from CDSCO to import and sell Lynparza (Olaparib) in India. Lynparza will ...

Olaparib in combination with Durvalumab is indicated for the maintenance treatment of adult patients with advanced or ...

Lynparza, in combination with Durvalumab, was also approved as a treatment for maintenance use by adult patients whose ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from ...

Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg in the U.S. market.

AstraZeneca Pharma India said that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Olaparib film-coated tablets 100 mg & 150 mg (Lynparza ...

GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A ...

Emcure Pharma Gets a Boost! Kotak's Rating Upgrade Explained, Good news for Emcure Pharma, Kotak Institutional has upgraded ...

Hyderabad: Natco Pharma, an Indian pharmaceutical company has announced the submission of an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification with the U.S. Food ...

AstraZeneca Pharma India has received approval from the CDSCO for Olaparib film-coated tablets, set to launch in India for ...